Different patterns of DNA methylation of the two distinct O6-methylguanine-DNA methyltransferase (O6-MGMT) promoter regions in colorectal cancer

Molecular Biology Reports

Volumn 40, Issue 5, 2013, Pages 3851-3857

  Mokarram, P ^a   Zamani, M ^a   Kavousipour, S ^a   Naghibalhossaini, F ^a   Irajie, C ^b   Moradi Sarabi, M ^a   Hosseini, S V ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

APC2; Colorectal cancer; K ras; MGMT; p16

Indexed keywords

ADENINE; GUANINE; K RAS PROTEIN; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN P16; PROTEIN P53;

ADULT; ARTICLE; CANCER GROWTH; CANCER INCIDENCE; CANCER PATIENT; CANCER TISSUE; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; ENZYME ACTIVITY; EPIGENETICS; FEMALE; GENE; GENE LOCUS; GENE MUTATION; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MGMT A GENE; MGMT B GENE; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROGNOSIS; PROMOTER REGION; START CODON;

ADULT; AGED; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; PROMOTER REGIONS, GENETIC;

EID: 84878404373     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-2465-3     Document Type: Article

References (44)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2001) Estimating the world cancer burden: globocan 2000. Int J Cancer 94:153-156. doi: 10.1002/ijc.1440
2. Yazdizadeh B, Jarrahi AM, Mortazavi H, Mohagheghi MA, Tahmasebi S, Nahvijo A (2005) Time trends in the occurrence of major GI cancers in Iran. Asian Pac J Cancer Prev 6:130-134
3. Hosseini SV, Izadpanah A, Yarmohammadi H (2004) Epidemiological changes in colorectal cancer in Shiraz, Iran: 1980-2000. ANZ J Surg 74:547-549. doi: 10.1111/j.1445-2197.2004.03064.x
4. Higashidani Y, Tamura S, Morita T, Tadokoro T, Yokoyama Y, Miyazaki J, Yang Y, Takeuchi S, Taguchi H, Onishi S (2003) Analysis of K-ras codon 12 mutation in flat and nodular variants of serrated adenoma in the colon. Dis Colon Rectum 46:327-332. doi: 10.1007/s10350-004-6551-z
5. Smith G, Carey FA, Beattie J, Wilkie MJ, Lightfoot TJ, Coxhead J, Garner RC, Steele RJ, Wolf CR (2002) Mutations in APC, Kirsten-ras, and p53-alternative genetic pathways to colorectal cancer. Proc Natl Acad Sci U S A 99:9433-9438. doi: 10.1073/pnas.122612899
6. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759-767. doi: 10.1016/0092-8674(90)90186-I
7. Baylin SB, Esteller M, Rountree MR, Bachman KE, Schuebel K, Herman JG (2001) Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum Mol Genet 10:687-692. doi: 10.1093/hmg/10.7.687
8. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP (1998) Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 72:141-196. doi: 10.1016/S0065-230X(08)60702-2
9. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP (1999) CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 96:8681-8686. doi: 10.1073/pnas.96.15.8681
10. Krtolica K, Krajnovic M, Usaj-Knezevic S, Babic D, Jovanovic D, Dimitrijevic B (2007) Comethylation of p16 and MGMT genes in colorectal carcinoma: correlation with clinicopathological features and prognostic value. World J Gastroenterol 13:1187-1194. doi: 1007-9327/13/1187.asp
11. Taghavi N, Biramijamal F, Sotoudeh M, Khademi H, Malekzadeh R, Moaven O, Memar B, A'Rabi A, Abbaszadegan MR (2010) p16INK4a hypermethylation and p53, p16 and MDM2 protein expression in esophageal squamous cell carcinoma. BMC Cancer 10:138. doi: 10.1186/1471-2407-10-138
12. Georgiou E, Kouidou S (2011) Epigenetically-targeted therapies for the treatment of hematological malignancies. Curr Med Chem 18:1757-1764. doi: 10.2174/092986711795496791
13. Zhong S, Fields CR, Su N, Pan YX, Robertson KD (2007) Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer. Oncogene 26:2621-2634. doi: 10.1038/sj.onc.1210041
14. Gonzalo V, Lozano JJ, Munoz J, Balaguer F, Pellise M, Rodriguez de Miguel C, Andreu M, Jover R, Llor X, Giraldez MD, Ocana T, Serradesanferm A, Alonso-Espinaco V, Jimeno M, Cuatrecasas M, Sendino O, Castellvi-Bel S, Castells A (2010) Aberrant gene promoter methylation associated with sporadic multiple colorectal cancer. PLoS ONE 5:e8777. doi: 10.1371/journal.pone.0008777
15. Costello JF, Futscher BW, Tano K, Graunke DM, Pieper RO (1994) Graded methylation in the promoter and body of the O6-methylguanine DNA methyltransferase (MGMT) gene correlates with MGMT expression in human glioma cells. J Biol Chem 269:17228-17237
16. Halford S, Rowan A, Sawyer E, Talbot I, Tomlinson I (2005) O(6)-methylguanine methyltransferase in colorectal cancers: detection of mutations, loss of expression, and weak association with G:c > A:t transitions. Gut 54:797-802. doi: 10.1136/gut.2004.059535
17. Nakagawachi T, Soejima H, Urano T, Zhao W, Higashimoto K, Satoh Y, Matsukura S, Kudo S, Kitajima Y, Harada H, Furukawa K, Matsuzaki H, Emi M, Nakabeppu Y, Miyazaki K, Sekiguchi M, Mukai T (2003) Silencing effect of CpG island hypermethylation and histone modifications on O6-methylguanine-DNA methyltransferase (MGMT) gene expression in human cancer. Oncogene 22:8835-8844. doi: 10.1038/sj.onc.1207183
18. Naghibalhossaini F, Hosseini HM, Mokarram P, Zamani M (2011) High frequency of genes' promoter methylation, but lack of braf v600e mutation among iranian colorectal cancer patients. Pathol Oncol Res. doi: 10.1007/s12253-011- 9388-5
19. Mokarram P, Naghibalhossaini F, Saberi Firoozi M, Hosseini SV, Izadpanah A, Salahi H, Malek-Hosseini SA, Talei A, Mojallal M (2008) Methylenetetrahydrofolate reductase C677T genotype affects promoter methylation of tumor-specific genes in sporadic colorectal cancer through an interaction with folate/vitamin B12 status. World J Gastroenterol 14:3662-3671. doi: 10.3748/wjg.14.3662
20. Blin N, Stafford DW (1976) A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res 3:2303-2308. doi: 10.1093/nar/3.9.2303
21. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 93:9821-9826
22. Sidhu S, Deep JS, Sobti RC, Sharma VL, Thaku H (2010) Methylation pattern of MGMT gene in relation to age, smoking, drinking and dietary habits as epigenetic biomarker in prostate cancer patients. Genet Eng Biotechnol J 2010(8):1-11
23. Wang J, Sasco AJ, Fu C, Xue H, Guo G, Hua Z, Zhou Q, Jiang Q, Xu B (2008) Aberrant DNA methylation of p16, MGMT, and hMLH1 genes in combination with MTHFR C677T genetic polymorphism in esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 17:118-125. doi: 10.1158/1055-9965.EPI-07-0733
24. Esteller M, Hamilton SR, Burger PC, Baylin SB, Herman JG (1999) Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 59:793-797
25. Silber JR, Bobola MS, Ghatan S, Blank A, Kolstoe DD, Berger MS (1998) O6-methylguanine-DNA methyltransferase activity in adult gliomas: relation to patient and tumor characteristics. Cancer Res 58:1068-1073
26. Xiao-fang L, Xian-chun S, Cui-sheng Z, Zheng X, Shao-jun L, Xian-ting Z, Shi-jie S (2010) Promoter hypermethylation of O6-methylguanine-DNA methyltransferase gene in cholangiocarcinoma. J Chin Clin Med 5(8):463-468
27. Löf-Ohlin ZM, Nilsson TK (2009) Pyrosequencing assays to study promoter CpG site methylation of the O6-MGMT, hMLH1, p14ARF, p16INK4a, RASSF1A, and APC1A genes. Oncol Rep 21:721-729. doi: 10.3892/or-00000277
28. Sciuscio D, Diserens AC, van Dommelen K, Martinet D, Jones G, Janzer RC, Pollo C, Hamou MF, Kaina B, Stupp R, Levivier M, Hegi ME (2011) Extent and patterns of MGMT promoter methylation in glioblastoma- and respective glioblastoma-derived spheres. Clin Cancer Res 17:255-266. doi: 10.1158/1078-0432.CCR-10-1931
29. Ye C, Shrubsole MJ, Cai Q, Ness R, Grady WM, Smalley W, Cai H, Washington K, Zheng W (2006) Promoter methylation status of the MGMT, hMLH1, and CDKN2A/p16 genes in non-neoplastic mucosa of patients with and without colorectal adenomas. Oncol Rep 16:429-435
30. Liu Y, Lan Q, Siegfried JM, Luketich JD, Keohavong P (2006) Aberrant promoter methylation of p16 and MGMT genes in lung tumors from smoking and never-smoking lung cancer patients. Neoplasia 8:46-51. doi: 10.1593/neo.05586
31. Servomaa K, Kiuru A, Kosma VM, Hirvikoski P, Rytomaa T (2000) p53 and K-ras gene mutations in carcinoma of the rectum among Finnish women. Mol Pathol 53:24-30. doi: 10.1136/mp.53.1.24
32. Mokarram P, Kumar K, Brim H, Naghibalhossaini F, Saberi-firoozi M, Nouraie M, Green R, Lee E, Smoot DT, Ashktorab H (2009) Distinct high-profile methylated genes in colorectal cancer. PLoS ONE 4:e7012. doi: 10.1371/journal.pone.0007012
33. De Vogel S, Weijenberg MP, Herman JG, Wouters KA, De Goeij AF, Van den Brandt PA, De Bruine AP, Van Engeland M (2009) MGMT and MLH1 promoter methylation versus APC, K-ras and BRAF gene mutations in colorectal cancer: indications for distinct pathways and sequence of events. Ann Oncol 20:1216-1222. doi: 10.1093/annonc/mdn782
34. Fuchikami M, Morinobu S, Segawa M, Okamoto Y, Yamawaki S, Ozaki N, Inoue T, Kusumi I, Koyama T, Tsuchiyama K, Terao T (2011) DNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression. PLoS ONE 6:e23881. doi: 10.1371/journal.pone. 0023881
35. Shacham-Shmueli E, Beny A, Geva R, Blachar A, Figer A, Aderka D (2011) Response to temozolomide in patients with metastatic colorectal cancer with loss of MGMT expression: a new approach in the era of personalized medicine? J Clin Oncol. doi: 10.1200/JCO.2010.32.0242
36. Shen L, Kondo Y, Rosner GL, Xiao L, Hernandez NS, Vilaythong J, Houlihan PS, Krouse RS, Prasad AR, Einspahr JG, Buckmeier J, Alberts DS, Hamilton SR, Issa JP (2005) MGMT promoter methylation and field defect in sporadic colorectal cancer. J Natl Cancer Inst 97:1330-1338. doi: 10.1093/jnci/dji275
37. Kumar K, Brim H, Giardiello F, Smoot DT, Nouraie M, Lee EL, Ashktorab H (2009) Distinct BRAF (V600E) and K-ras mutations in high microsatellite instability sporadic colorectal cancer in African Americans. Clin Cancer Res 15:1155-1161. doi: 10.1158/1078-0432.CCR-08-1029
38. Brim H, Mokarram P, Naghibalhossaini F, Saberi-Firoozi M, Al-Mandhari M, Al-Mawaly K, Al-Mjeni R, Al-Sayegh A, Raeburn S, Lee E, Giardiello F, Smoot DT, Vilkin A, Boland CR, Goel A, Hafezi M, Nouraie M, Ashktorab H (2008) Impact of BRAF, MLH1 on the incidence of microsatellite instability high colorectal cancer in populations based study. Mol Cancer 7:68. doi: 10.1186/1476-4598-7-68
39. Haydon AM, Jass JR (2002) Emerging pathways in colorectal-cancer development. Lancet Oncol 3:83-88. doi: 10.1016/S1470-2045(02)00649-6
40. Bauer KM, Hummon AB, Buechler S (2011) Right-side and left-side colon cancer follow different pathways to relapse. Mol Carcinog. doi: 10.1002/mc.20804
41. Sugai T, Habano W, Jiao YF, Tsukahara M, Takeda Y, Otsuka K, Nakamura S (2006) Analysis of molecular alterations in left- and right-sided colorectal carcinomas reveals distinct pathways of carcinogenesis: proposal for new molecular profile of colorectal carcinomas. J Mol Diagn 8:193-201. doi: 10.2353/jmoldx.2006.050052
42. Jass JR (2007) Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 50:113-130. doi: 10.1111/j.1365-2559.2006.02549.x
43. Cai FF, Kohler C, Zhang B, Wang MH, Chen WJ, Zhong XY (2011) Epigenetic therapy for breast cancer. Int J Mol Sci 12:4465-4487. doi: 10.3390/ijms12074465
44. Santini V, Kantarjian HM, Issa JP (2001) Changes in DNA methylation in neoplasia: pathophysiology and therapeutic implications. Ann Intern Med 134:573-586